Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhonghua Wai Ke Za Zhi ; 58(1): 61-69, 2020 Jan 01.
Artigo em Chinês | MEDLINE | ID: mdl-31902173

RESUMO

Esophageal cancer surgery originated in the early 20(th) century. However, the true meaning of trans-thoracic esophagectomy and digestive tract reconstruction began in the 1930s. Almost at the same time, Japan and Western countries began the surgical exploration of esophageal cancer. Based on the pathological type of esophageal cancer in Asia, squamous cell carcinoma is the majority, and its biological characteristics and treatment strategies are different from those of European and American patients. After more than eighty years of development, the surgical treatment of esophageal cancer in Japan has been developed from the initial attempt, deep cultivation practice to the pursuit of excellence, and explored a set of more advanced surgical techniques and diagnostic strategies, which is unique in the world. On the basis of the establishment of the Japanese Society of Esophagus, Japanese scholars have developed and irregularly updated the Japanese Classification of Esophageal Cancer and published the professional academic journal Esophagus. The Japanese Clinical Oncology Group organized a number of phase Ⅲ clinical studies on esophageal cancer, providing strong evidence for the diagnosis and treatment of esophageal squamous carcinoma. Focused on the origin, development, current situation and future of esophageal cancer surgery in Japan, this paper summarized the development of esophageal cancer surgery in Japan through literature review, interviews with senior experts and Hot topics of esophageal cancer surgery-questionnaire survey of Japanese experts.


Assuntos
Carcinoma de Células Escamosas/cirurgia , Neoplasias Esofágicas/cirurgia , Esofagectomia/história , Carcinoma de Células Escamosas/história , Neoplasias Esofágicas/história , Esofagectomia/tendências , História do Século XX , História do Século XXI , Humanos , Japão , Estados Unidos
3.
J BUON ; 22(4): 1088-1091, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28952239

RESUMO

Esophageal cancer is one of the deadliest cancers due to its aggressive behavior and poor survival. It was mentioned in the works of ancient Chinese and Arabo-islamic physicians, centuries before the recognition of high incidence in the Asian esophageal cancer belt. Till the 19th century the disease was considered incurable and the main goal of the proposed treatments was to alleviate dysphagia and pain. The introduction of esophagoscope in 1868 by Adolf Kussmaul (1822-1902) contributed to the observation of the living esophagus and to the diagnosis of esophageal pathologies, paving the way for new therapeutic approaches. In 1877, Vincenz Czerny (1842-1916) performed the first successful resection of the cervical esophagus for carcinoma, followed by Franz Torek (1861-1938) who carried out in 1913 the first successful subtotal thoracic esophagectomy and Tohru Ohsawa (1882-1984) who performed the world's first esophagectomy with an intrathoracic esophagogastric anastomosis. Nowadays, despite the advent of biomedical technology and the development of operation techniques, the surgical treatment of esophagus still remains a challenge.


Assuntos
Carcinoma de Células Escamosas/história , Neoplasias Esofágicas/história , Idoso , Anastomose Cirúrgica/história , Anastomose Cirúrgica/métodos , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Transtornos de Deglutição/história , Transtornos de Deglutição/patologia , Transtornos de Deglutição/cirurgia , Neoplasias Esofágicas/patologia , Neoplasias Esofágicas/cirurgia , Esofagectomia/história , Esofagectomia/métodos , Esôfago/patologia , Esôfago/cirurgia , Feminino , História do Século XIX , História do Século XX , Humanos , Masculino , Pessoa de Meia-Idade
4.
PLoS One ; 12(3): e0173211, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28267769

RESUMO

BACKGROUND: Feicheng County is a high-risk area for esophageal cancer in Shandong province, China. It is important to determine the long-term spatio-temporal trends in epidemiological characteristics and the burden of esophageal cancer, especially since the implementation of the national esophageal cancer screening program for early detection and treatment in 2005. METHODS: The data collected in Feicheng County from 2001 to 2012 was extracted from the whole-population cancer registry system. The incidence, mortality, disability-adjusted life years (DALY) and changing trends in esophageal cancer according to age and sex were calculated and described. RESULTS: The incidence rate of esophageal cancer in Feicheng was consistently high, and increased significantly for male, but not for female from 2001 to 2012, according to the joinpoint regression analysis. The highest and lowest yearly crude incidence rates were 160.78 and 95.97 per 100000 for males, and 81.36 and 52.17 per 100000 for females. The highest and lowest crude yearly mortality rates were 122.26 and 94.40 per 100000 for males, and 60.75 and 49.35 per 100000for females. Esophageal squamous cell carcinoma was the main pathology type and the tumor location changed significantly from 2001 to 2012. Overall, the DALY remained roughly stable and was estimated as 11.50 for males and 4.90 for females per 1000 people. The burden was mainly caused by premature death. There is an obvious spatial pattern in the distribution of incidence density and burden. CONCLUSION: Esophageal cancer remains a public health issue in Feicheng County with a high incidence, mortality and disease burden. The incidence and burden have obvious spatial heterogeneity, and further studies should be conducted to identify geographical risk factors for precise local prevention and control measures.


Assuntos
Efeitos Psicossociais da Doença , Neoplasias Esofágicas/epidemiologia , Vigilância da População , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Algoritmos , China/epidemiologia , Pessoas com Deficiência/estatística & dados numéricos , Neoplasias Esofágicas/história , Neoplasias Esofágicas/patologia , Feminino , História do Século XXI , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Mortalidade , Anos de Vida Ajustados por Qualidade de Vida , Sistema de Registros , Análise Espaço-Temporal , Adulto Jovem
6.
Praxis (Bern 1994) ; 103(16): 955-60, 2014 Aug 06.
Artigo em Alemão | MEDLINE | ID: mdl-25097164

RESUMO

520 new cases of esophageal carcinoma are diagnosed in Switzerland per year. 80% of these patients eventually die from their disease despite recent advances in surgical technique and systemic treatment. The first successful thoracic esophageal resection for carcinoma was performed in 1913, but only the introduction of modern anesthesia with oral intubation and positive pressure ventilation made thoracic operations routinely feasible. Esophageal resection can be performed open or minimally invasive. The minimally invasive esophageal resection has been proven to be safe with comparable mortality to open resection. Also, there is no difference in terms of radicality of the operation. Overall survival seems to be equal in published series, but results of prospective trials are still pending.


Assuntos
Adenocarcinoma/história , Adenocarcinoma/cirurgia , Carcinoma de Células Escamosas/história , Carcinoma de Células Escamosas/cirurgia , Neoplasias Esofágicas/história , Neoplasias Esofágicas/cirurgia , Esofagectomia/história , Esofagectomia/métodos , Esofagoscopia/história , Esofagoscopia/métodos , Esofagostomia/história , Esofagostomia/métodos , Procedimentos Cirúrgicos Minimamente Invasivos/história , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Adenocarcinoma/patologia , Carcinoma de Células Escamosas/patologia , Neoplasias Esofágicas/patologia , História do Século XVII , História do Século XVIII , História do Século XIX , História do Século XX , História do Século XXI , História Antiga , História Medieval , Humanos , Estadiamento de Neoplasias
7.
Thorac Surg Clin ; 23(4): 461-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24199696

RESUMO

TNM cancer staging, conceived 70 years ago, was first applied to the esophagus in 1977. Prior staging was neither data-driven nor harmonized with stomach cancer. Machine-learning analysis of worldwide data addressed these shortcomings in the 7th edition. The 8th edition considers 6 problems in attempting to advance esophageal cancer staging.


Assuntos
Neoplasias Esofágicas/história , Estadiamento de Neoplasias/história , Neoplasias Esofágicas/patologia , História do Século XX , História do Século XXI , Humanos
8.
Gen Thorac Cardiovasc Surg ; 61(4): 201-7, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23404311

RESUMO

Advanced esophageal tumors have been a challenge for surgery since the very beginning, and these challenges continue still today. In the early period of three-field lymphadenectomy (late 1980s), there was no special attention paid to tracheal necrosis after such an extended operation. In 1988, we reported functional mediastinal dissection preserving the right bronchial artery to prevent such complications. In 1993, we reported that the survival after three-field lymphadenectomy was better than that after en-bloc esophagectomy, and then the lymph node compartment classification based on the metastatic rate and the survival rate. This concept was introduced into the 9th edition of the Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus published in 1999. In early 1980s, combined resection of the neighboring organs was initiated for a locally advanced esophageal cancer. Almost all patients who underwent such an operation, however, died of metastasis in the short-term after surgery without any additional treatment. In 1987, we reported several types of tracheal repair using the latissimus dorsi muscle flap, as a less-invasive surgery that enabled adjuvant or additive therapy, after resection of the trachea involved by cancer. Then in 2004, we demonstrated that the canine aorta could be resected even immediately after aortic stenting. This suggests that an esophageal cancer involving the aorta can be resected using a new technique. To meet the challenges posed by advanced esophageal cancer, the help of other specialized fields besides esophageal surgery is needed: "The specialist must know everything of something, something of everything."


Assuntos
Neoplasias Esofágicas/história , Esofagectomia/história , Excisão de Linfonodo/história , Animais , Quimiorradioterapia/história , Neoplasias Esofágicas/terapia , Esofagectomia/métodos , Esofagectomia/tendências , História do Século XX , História do Século XXI , Humanos , Excisão de Linfonodo/métodos , Taxa de Sobrevida
10.
J Gastroenterol Hepatol ; 26 Suppl 1: 11-30, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21199510

RESUMO

Interpretation of exploding knowledge about Barrett's esophagus is impaired by use of several conflicting definitions. Because any histological type of esophageal columnar metaplasia carries risk for esophageal adenocarcinoma, the diagnosis of Barrett's esophagus should no longer require demonstration of intestinal-type metaplasia. Endoscopic recognition and grading of Barrett's esophagus remains a significant source of ambiguity. Reflux disease is a key factor for development of Barrett's esophagus, but other factors must underlie its development, since it occurs in only a minority of reflux disease patients. Neither antireflux surgery nor proton pump inhibitor (PPI) therapy has major impacts on cancer risk. Within a year, a major trial should indicate whether low-dose aspirin usefully reduces cancer risk. The best referral centers have transformed the accuracy of screening and surveillance for early curable esophageal adenocarcinoma by use of enhanced and novel endoscopic imaging, visually-guided, rather than blind biopsies and by partnership with expert pathologists. General endoscopists now need to upgrade their skills and equipment so that they can rely mainly on visual targeting of biopsies on mucosal areas of concern in their surveillance practice. General pathologists need to greatly improve their interpretation of biopsies. Endoscopic therapy now achieves very high rates of cure of high-grade dysplasia and esophageal adenocarcinoma with minimal morbidity and risk. Such results will only be achieved by skilled interventional endoscopists. Esophagectomy should now be mainly restricted to patients whose cancer has extended into and beyond the submucosa. Weighing risks and benefits in the management of Barrett's esophagus is difficult, as is the process of adequately informing patients about their specific cancer risk.


Assuntos
Adenocarcinoma/história , Esôfago de Barrett/história , Neoplasias Esofágicas/história , Lesões Pré-Cancerosas/história , Adenocarcinoma/diagnóstico , Adenocarcinoma/epidemiologia , Adenocarcinoma/terapia , Esôfago de Barrett/diagnóstico , Esôfago de Barrett/epidemiologia , Esôfago de Barrett/terapia , Progressão da Doença , Detecção Precoce de Câncer , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/epidemiologia , Neoplasias Esofágicas/terapia , Esofagoscopia , Medicina Baseada em Evidências , História do Século XX , História do Século XXI , Humanos , Programas de Rastreamento/métodos , Lesões Pré-Cancerosas/diagnóstico , Lesões Pré-Cancerosas/epidemiologia , Lesões Pré-Cancerosas/terapia , Valor Preditivo dos Testes , Medição de Risco , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento
12.
World J Gastroenterol ; 16(30): 3793-803, 2010 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-20698042

RESUMO

The management of esophageal cancer has been evolving over the past 30 years. In the United States, multimodality treatment combining chemotherapy and radiotherapy (RT) prior to surgical resection has come to be accepted by many as the standard of care, although debate about its overall effect on survival still exists, and rightfully so. Despite recent improvements in detection and treatment, the overall survival of patients with esophageal cancer remains lower than most solid tumors, which highlights why further advances are so desperately needed. The aim of this article is to provide a complete review of the history of esophageal cancer treatment with the addition of chemotherapy, RT, and more recently, targeted agents to the surgical management of resectable disease.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Esofágicas/terapia , Esofagectomia , Terapia Neoadjuvante , Protocolos de Quimioterapia Combinada Antineoplásica/história , Quimioterapia Adjuvante , Neoplasias Esofágicas/história , Esofagectomia/história , História do Século XX , História do Século XXI , Humanos , Excisão de Linfonodo , Seleção de Pacientes , Radioterapia Adjuvante , Resultado do Tratamento
13.
Gastroenterology ; 138(3): 854-69, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20080098

RESUMO

This report is an adjunct to the American Gastroenterological Association Institute's medical position statement and technical review on the management of Barrett's esophagus, which will be published in the near future. Those documents will consider a number of broad questions on the diagnosis, clinical features, and management of patients with Barrett's esophagus, and the reader is referred to the technical review for an in-depth discussion of those topics. In this report, we review historical, molecular, and endoscopic therapeutic aspects of Barrett's esophagus that are of interest to clinicians and researchers.


Assuntos
Esôfago de Barrett/terapia , Neoplasias Esofágicas/terapia , Esofagoscopia , Esôfago/patologia , Lesões Pré-Cancerosas/terapia , Esôfago de Barrett/etiologia , Esôfago de Barrett/história , Esôfago de Barrett/patologia , Transformação Celular Neoplásica/patologia , Neoplasias Esofágicas/história , Neoplasias Esofágicas/patologia , Esofagoscopia/história , Esofagoscopia/métodos , História do Século XIX , História do Século XX , Humanos , Metaplasia , Lesões Pré-Cancerosas/etiologia , Lesões Pré-Cancerosas/história , Lesões Pré-Cancerosas/patologia , Fatores de Risco , Resultado do Tratamento
14.
Gastroenterol Clin North Am ; 38(1): 1-15, vii, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19327564

RESUMO

The history of esophageal cancer dates back to ancient Egyptian times, circa 3000 bc. Since then, the progress in the diagnosis and treatment of esophageal cancer has been steady. Over the last few centuries there have been advancements in the visualization and removal of these lesions, but with no real overall impact on survival rates. The twenty-first century is the time to make major progress in not only improving survival rates, but also in diagnosing esophageal cancer in the very early stages.


Assuntos
Neoplasias Esofágicas/história , História do Século XVI , História do Século XVII , História do Século XVIII , História do Século XIX , História do Século XX , História do Século XXI , História Antiga , História Medieval , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA